• A2 Milk shares jump again as China worries start to ease

    A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side.

    It has been a big few weeks for A2 Milk Company Ltd (ASX: A2M) shares, and Tuesday is bringing more good news for investors.

    At the time of writing, the A2 Milk share price is up 3.63% to $7.99.

    That means the ASX infant formula stock is now up 54% over the past month.

    The latest move comes after the company provided investors with an update on its China supply issues, along with better-than-expected preliminary FY26 results.

    So, what changed today?

    China supply issues ease

    According to the release, A2 Milk said the supply chain problems that hit its China label infant milk formula business have now been mostly sorted out.

    The issue came through in the fourth quarter, when the company struggled to keep enough product available.

    A2 Milk said this was caused by a few things, including strong demand in the previous quarter, freight challenges, production backlogs, longer release times, and extra customs clearance requirements.

    As a result, some customers moved to other brands. Others switched across to A2 Milk’s English label products.

    However, things now look to be improving.

    The company said product flows to distributors and retailers have materially improved across both its China label and English label products, with stock levels returning to target.

    A2 Milk is now trying to win back previous China label users, while also speeding up new customer recruitment with its retail and distribution partners.

    Full-year result holds up

    The preliminary FY26 result also gave the market something to work with.

    A2 Milk expects revenue of approximately NZ$1.97 billion, up more than 12% on FY25. That is slightly ahead of the guidance it gave in April, which was for low to mid-double-digit growth.

    The company also expects its EBITDA margin to land at the high end of its 14% to 14.5% guidance range.

    Reported net profit after tax (NPAT) is tipped to be slightly higher than FY25, while cash conversion is expected to be around 70%. That’s well ahead of the 50% cash conversion guidance given in April.

    There was also decent growth outside the China label business. A2 Milk said English label infant formula, Other Nutritionals, and Liquid Milk all performed well and finished significantly higher than FY25.

    Can the rally keep going?

    A2 Milk has had plenty go its way over the past few weeks.

    Last month, it received approval from China’s State Administration for Market Regulation to transition its China label infant formula product registrations to a2 branded products.

    It also declared a NZ$300 million special dividend, equal to 41.362 cents per share. That dividend is due to trade ex-dividend on 8 July.

    After a 54% gain in a month, A2 Milk is no longer flying under the radar.

    The next major test will be the company’s audited FY26 result and FY27 outlook commentary on 17 August.

    The post A2 Milk shares jump again as China worries start to ease appeared first on The Motley Fool Australia.

    Should you invest $1,000 in A2 Milk right now?

    Before you buy A2 Milk shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and A2 Milk wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 13 ASX 200 shares that doubled in value in FY26

    One girl leapfrogs over her friend's back.

     

    S&P/ASX 200 Index (ASX: XJO) shares rose by 2.77% and provided total gross returns (including dividends) of 7% in FY26.

    Thirteen ASX 200 shares doubled in value — or better — over the 12 months.

    Three of them were ASX 200 gold miners, which benefited from an 18% rise in the gold price last year.

    Four were lithium miners, which generated turbocharged earnings amid a 278% lift in the spodumene price and a 160% rise in the carbonate price over FY26.

    While healthcare was the worst-performing sector, the ASX 200’s fastest rising stock came from it and blasted 1,786% higher!

    Let’s check out this group of ASX 200 double baggers for FY26.

    Double-baggers of FY26

    1. 4DMedical Ltd (ASX: 4DX)

    This ASX healthcare share skyrocketed 1,786% in FY26 to close out the year at $4.53.

    The respiratory imaging technology company gained US Food and Drug Administration (FDA) approval for its CT:VQ product in September 2025.

    CT:VQ has since been deployed at several well-known academic hospitals and clinics.

    One broker thinks there is more room to run for 4DMedical shares in FY27.

    2. Minerals 260 Ltd (ASX: MI6)

    This ASX 200 gold share ripped 508% to finish FY26 at 73 cents.

    Minerals 260 is building the Bullabulling Gold Project near Kalgoorlie in Western Australia’s Eastern Goldfields region.

    3. Elevra Lithium Ltd (ASX: ELV)

    This ASX 200 lithium share flew 327% to $9.60 over FY26.

    Elevra has a globally diversified portfolio of mines and projects across Québec, North Carolina, Ghana, and Western Australia.

    4. PLS Group Ltd (ASX: PLS)

    This fellow ASX lithium share leapt 275% to close out FY26 at $5.02.

    The company’s flagship project is Pilgangoora, the world’s largest independent hard-rock lithium mine.

    Formerly known as Pilbara Minerals, PLS Group was the best performer among the ASX 200 large-cap shares last year.

    5. Electro Optic Systems Holdings Ltd (ASX: EOS)

    The Electro Optic Systems share price increased 261% to close the year at $10.30.

    This made Electro Optic the best-performing stock of the industrials sector in FY26.

    The company specialises in defence technology, advanced weapon systems, and counter-drone solutions.

    6. Mineral Resources Ltd (ASX: MIN)

    The Mineral Resources share price rose 188% in FY26.

    The ASX large-cap mining share finished the year at $62.07.

    Value investors returned to Mineral Resources after corporate governance and financial problems crushed the stock in FY25.

    Mineral Resources reported its best half-year result ever for 1H FY26. The miner reported record revenue of $3.1 billion and EBITDA of $1.2 billion due to rising lithium prices and the successful ramp-up of its Onslow iron ore project.

    7. NRW Holdings Limited (ASX: NWH)

    This ASX 200 industrials share soared 149% to finish the year at $7.44.

    8. Liontown Ltd (ASX: LTR)

    This ASX 200 lithium share rose 142% to finish the year at $1.69.

    For 1H FY26, Liontown reported doubled revenue after a 70% lift in spodumene production.

    In 3Q FY26, Liontown became cash flow positive and hit its 1.5Mtpa annualised underground run-rate ahead of schedule.

    9. SRG Global Ltd (ASX: SRG)

    This ASX 200 industrials share rose 136% to finish the year at $3.98.

    10. Codan Ltd (ASX: CDA)

    This ASX 200 tech share lifted 119.5% to finish the year at $44.14.

    ASX 200 tech shares tanked in FY26, with only four finishing the year in the green.

    11. Kingsgate Consolidated Ltd (ASX: KCN)

    This ASX 200 gold share rose 119% to finish the year at $4.95.

    12. Lynas Rare Earths Ltd (ASX: LYC)

    This ASX 200 rare earths share increased 115% to close out the year at $18.06.

    An 80% lift in the neodymium price, and restricted rare earths exports out of China helped Lynas shares grow in FY26.

    13. Alkane Resources Ltd (ASX: ALK)

    This ASX 200 gold share rose 92% to finish the year at $1.37.

    The post 13 ASX 200 shares that doubled in value in FY26 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in 4DMedical right now?

    Before you buy 4DMedical shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 4DMedical wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has recommended Srg Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Qube Holdings: Supreme Court approves takeover scheme

    A judge sitting in a blurred background reaches forward to strike his gavel on the strikeplate on his judge's bench.

    The Qube Holdings Ltd (ASX: QUB) share price is in focus today after the company announced Supreme Court approval for its scheme of arrangement, paving the way for Rubik Australia Pty Limited to acquire all Qube shares.

    What did Qube Holdings report?

    • The Supreme Court of NSW has approved the scheme of arrangement with Rubik Australia Pty Limited.
    • Qube Holdings will arrange for court orders to be lodged with ASIC on 8 July 2026.
    • Once lodged, the scheme will become legally effective and all Qube shares will be acquired by the bidder.
    • Qube intends to apply for its ASX quotation to be suspended after close of trading on 8 July 2026.

    What else do investors need to know?

    This marks the final regulatory hurdle for the proposed takeover first announced in February 2026. Once the court orders are lodged with ASIC, shareholders will see their holdings acquired under the scheme.

    The company will shortly move to suspend trading in Qube shares, with completion of the acquisition process expected to occur as outlined in earlier announcements. Investors should look out for further updates as the acquisition is formally completed.

    What’s next for Qube?

    With final court and regulatory approvals in hand, Qube Holdings will now progress to complete the scheme of arrangement. This includes delisting Qube from the ASX and transferring all shares to Rubik Australia Pty Limited as planned.

    Shareholders do not need to take any action at this stage. Qube will communicate further details about payment and the end of share trading as the timeline progresses.

    Qube share price snapshot

    Over the past 12 months, Qube shares have risen 20%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

    View Original Announcement

    The post Qube Holdings: Supreme Court approves takeover scheme appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Qube right now?

    Before you buy Qube shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Qube wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.